Search

Your search keyword '"Heiblig M"' showing total 3 results
Start Over Author "Heiblig M" Journal blood
3 results on '"Heiblig M"'

1. Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.

Author

Heiblig M, Ferrada MA, Koster MJ, Barba T, Gerfaud-Valentin M, Mékinian A, Coelho H, Fossard G, Barraco F, Galicier L, Bienvenu B, Hirsch P, Vial G, Boutin AB, Galland J, Le Guenno G, Bigot A, Warrington KJ, Kermani TA, Grayson PC, Patel BA, Beck DB, Jamilloux Y, Fenaux P, and Sujobert P

Subjects
Nitriles, Pyrazoles pharmacology, Pyrazoles therapeutic use, Pyrimidines, Retrospective Studies, Janus Kinase Inhibitors pharmacology, Myelodysplastic Syndromes drug therapy, Skin Diseases, Genetic drug therapy
Published
2022
Full Text
View/download PDF

2. Therapeutic options in VEXAS syndrome: insights from a retrospective series.

Author

Bourbon E, Heiblig M, Gerfaud Valentin M, Barba T, Durel CA, Lega JC, Barraco F, Sève P, Jamilloux Y, and Sujobert P

Subjects
Humans, Syndrome, Genetic Diseases, Inborn enzymology, Genetic Diseases, Inborn genetics, Mutation, Mutation, Missense, Myeloproliferative Disorders enzymology, Myeloproliferative Disorders genetics, Ubiquitin-Activating Enzymes genetics
Published
2021
Full Text
View/download PDF

3. Comprehensive analysis of a myeloperoxidase-negative acute promyelocytic leukemia.

Author

Heiblig M, Paubelle E, Plesa A, Geay MO, Manzoni D, Gazzo S, Tigaud I, Callet-Bauchu E, Huet S, Salles G, Thomas X, Hayette S, and Sujobert P

Subjects
Humans, Male, Middle Aged, Peroxidase, Blast Crisis blood, Blast Crisis diagnosis, Blast Crisis genetics, Blast Crisis pathology, Leukemia, Promyelocytic, Acute blood, Leukemia, Promyelocytic, Acute diagnosis, Leukemia, Promyelocytic, Acute genetics, Leukemia, Promyelocytic, Acute pathology, Oncogene Proteins, Fusion blood, Oncogene Proteins, Fusion genetics
Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results